The FDA has issued warnings against the off-brand versions, citing safety concerns. "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs ...

Since the shortage began, specialty and compounding pharmacies have been allowed to sell off-brand versions of the weight loss drug. People can get prescriptions through telehealth, and the cost ...

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal ...

Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...